カテゴリ： MarketLine, アメリカ, 企業調査

Berkshire Hathaway Inc：企業の戦略・SWOT・財務分析

◆英語タイトル：Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY5154
◆発行会社（調査会社）：MarketLine
◆発行日：2020年3月
◆ページ数：63
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Financial Services
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Berkshire Hathaway Inc – Strategy, SWOT and Corporate Finance Report
Summary

Berkshire Hathaway Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Berkshire Hathaway Inc (Berkshire) is a diversified holding group. The group, through its subsidiaries, focuses on insurance and reinsurance, freight rail transportation and utility and energy generation and distribution business. It offers property and casualty insurance and reinsurance, and life, health and accident reinsurance products. The group operates railroad systems in North America, which serve the Midwest, Southwestern, Western, Pacific Northwest, and Southeastern ports and regions of the US. Berkshire also focuses on manufacturing, service and retailing, finance and financial products activities. The group primarily operates in the US, Western Europe and Asia Pacific region. Berkshire is headquartered in Omaha, Nebraska, the US.

The group reported direct premiums written of US$45,624 million for the fiscal year ended December 2018 (FY2018), an increase of 13.4% over that in FY2017. Its net premiums written were US$59,216 million in FY2018, a decrease of 4.9% over that in FY2017.

Scope

- Detailed information on Berkshire Hathaway Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Berkshire Hathaway Inc in the form of a SWOT analysis
- An in-depth view of the business model of Berkshire Hathaway Inc including a breakdown and examination of key business segments
- Intelligence on Berkshire Hathaway Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Berkshire Hathaway Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Berkshire Hathaway Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Berkshire Hathaway Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Berkshire Hathaway Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Berkshire Hathaway Inc: Company Overview
Berkshire Hathaway Inc: Overview and Key Facts
Berkshire Hathaway Inc: Overview
Berkshire Hathaway Inc: Key Facts
Berkshire Hathaway Inc: Key Employees
Berkshire Hathaway Inc: Key Employee Biographies
Berkshire Hathaway Inc: Major Products and Services
Berkshire Hathaway Inc: Company History
Berkshire Hathaway Inc: Management Statement
Berkshire Hathaway Inc: Locations and Subsidiaries
Berkshire Hathaway Inc: Key Competitors
Berkshire Hathaway Inc: Company Analysis
Berkshire Hathaway Inc: Business Description
Berkshire Hathaway Inc: SWOT Analysis
Berkshire Hathaway Inc: SWOT Overview
Berkshire Hathaway Inc: Strengths
Berkshire Hathaway Inc: Weaknesses
Berkshire Hathaway Inc: Opportunities
Berkshire Hathaway Inc: Threats
Berkshire Hathaway Inc: Corporate Financial Deals Activity
Berkshire Hathaway Inc: Financial Deals Overview
Berkshire Hathaway Inc: Targets and Partners
Berkshire Hathaway Inc: Top Deals 2016 – 2020YTD*
Berkshire Hathaway Inc: Advisors
Berkshire Hathaway Inc: Top Legal Advisors
Berkshire Hathaway Inc: Top Financial Advisors
Berkshire Hathaway Inc: Mergers and Acquisitions
Berkshire Hathaway Inc: Corporate Venturing
Berkshire Hathaway Inc: Capital Raising
Berkshire Hathaway Inc: Divestments
Berkshire Hathaway Inc: Private Equity and Ownership
Berkshire Hathaway Inc: Recent Developments
Berkshire Hathaway Inc: News and Events Summary
Berkshire Hathaway Inc: Business Expansion
Berkshire Hathaway Inc: Contracts
Berkshire Hathaway Inc: Corporate Governance
Berkshire Hathaway Inc: Financial Deals
Berkshire Hathaway Inc: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Berkshire Hathaway Inc: Key Facts
Table 2: Berkshire Hathaway Inc: Key Employees
Table 3: Berkshire Hathaway Inc: Company History
Table 4: Berkshire Hathaway Inc: Locations and Subsidiaries
Table 5: Berkshire Hathaway Inc: Key Competitors
Table 6: Berkshire Hathaway Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Berkshire Hathaway Inc: M&A Activity by Geography (TTM*)
Table 8: Berkshire Hathaway Inc: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Berkshire Hathaway Inc: M&A Average Deal Size - Value (US$m)
Table 10: Berkshire Hathaway Inc: Targets and Partners
Table 11: Berkshire Hathaway Inc: Top Deals 2016 - 2020YTD*
Table 12: Berkshire Hathaway Inc: Legal Advisor Ranking by Value (US$m)
Table 13: Berkshire Hathaway Inc: Financial Advisor Ranking by Value (US$m)
Table 14: Berkshire Hathaway Inc: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Berkshire Hathaway Inc: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Berkshire Hathaway Inc: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 17: Berkshire Hathaway Inc: Corporate Venturing by Geography (2016 - YTD*2020)
Table 18: Berkshire Hathaway Inc: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 19: Berkshire Hathaway Inc: Capital Raising by Deal Type (2016 - YTD*2020)
Table 20: Berkshire Hathaway Inc: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 21: Berkshire Hathaway Inc: Divestments by Geography (2016 - YTD*2020)
Table 22: Berkshire Hathaway Inc: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 23: Berkshire Hathaway Inc: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 24: Berkshire Hathaway Inc: News and Events Summary
Table 25: Berkshire Hathaway Inc: Business Expansion
Table 26: Berkshire Hathaway Inc: Contracts
Table 27: Berkshire Hathaway Inc: Corporate Governance
Table 28: Berkshire Hathaway Inc: Financial Deals
Table 29: Berkshire Hathaway Inc: Strategy and Operations

★海外企業調査レポート[Berkshire Hathaway Inc：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Currence Holding B.V.：企業の戦略・SWOT・財務情報
    Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vascular Biogenics Ltd (VBLT)：企業の財務・戦略的SWOT分析
    Summary Vascular Biogenics Ltd (VBL Therapeutics) is a biopharmaceutical company. It discovers, develops and commercializes gene-therapy medicines for the treatment of cancer and inflammatory diseases. The company’s lead product candidate VB-111, a gene-based biologic agent is developed to treat rec …
  • Voyager Therapeutics Inc (VYGR)：企業の財務・戦略的SWOT分析
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …
  • CNP Assurances SA：企業のM&A・事業提携・投資動向
    CNP Assurances SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CNP Assurances SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Hybrigenics SA (ALHYG)：製薬・医療：M&Aディール及び事業提携情報
    Summary Hybrigenics SA (Hybrigenics) is a biopharmaceutical company that develops new targets and therapies against proliferative and non-cancerous diseases. Its lead product candidate Inecalcitol, is a vitamin D receptor agonist being assessed for various cancer indications including prostate cance …
  • Barry-Wehmiller Companies, Inc.：企業の戦略・SWOT・財務情報
    Barry-Wehmiller Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barry-Wehmiller Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • eHealthInsurance Services Inc：企業の戦略的SWOT分析
    eHealthInsurance Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Pabulum Limited：企業の戦略・SWOT・財務分析
    Pabulum Limited - Strategy, SWOT and Corporate Finance Report Summary Pabulum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Marathon Petroleum Corporation：企業の戦略・SWOT・財務情報
    Marathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Louisiana-Pacific Corporation：戦略・SWOT・企業財務分析
    Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • M.M.Warburg & CO KGaA：企業の戦略・SWOT・財務情報
    M.M.Warburg & CO KGaA - Strategy, SWOT and Corporate Finance Report Summary M.M.Warburg & CO KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Japan Post Holdings Co., Ltd.：企業の戦略・SWOT・財務情報
    Japan Post Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Japan Post Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Jacobs Engineering Group Inc (JEC)：企業の財務・戦略的SWOT分析
    Jacobs Engineering Group Inc (JEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Almirall S.A.：企業の戦略・SWOT・財務分析
    Almirall S.A. - Strategy, SWOT and Corporate Finance Report Summary Almirall S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Slavneft-Megionneftegaz (MFGS)：企業の財務・戦略的SWOT分析
    Summary Slavneft-Megionneftegaz (Megionneftegaz), a subsidiary of Slavneft, is an oil and gas company that operates oil fields. The company’s activities include appraisal of oil and gas fields, oil and gas production, and well drilling and operation. Megionneftegaz develops and introduces advanced t …
  • Mologen AG (MGN)：企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology engaged in the development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products which include MGN1601, and others. It also engaged in developing EnanDIM product to treat antitumor efficacy by stimulatin …
  • Alliance Bernstein Private Clients：企業の戦略・SWOT・財務情報
    Alliance Bernstein Private Clients - Strategy, SWOT and Corporate Finance Report Summary Alliance Bernstein Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Alterna Savings and Credit Union Limited：企業の戦略・SWOT・財務情報
    Alterna Savings and Credit Union Limited - Strategy, SWOT and Corporate Finance Report Summary Alterna Savings and Credit Union Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • OSE Immunotherapeutics (OSE)：企業の財務・戦略的SWOT分析
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …
  • WAVE Life Sciences Ltd (WVE)：製薬・医療：M&Aディール及び事業提携情報
    Summary WAVE Life Sciences Ltd (WAVE Life Sciences), formerly WAVE Life Sciences Pte Ltd is a genetic medicine company that develops stereopure nucleic acid therapies. The company's pipeline products comprise multiple oligonucleotide modalities such as exon-skipping and single-stranded RNAi, and ant …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆